Skip to content

Ambulatory Pessary Trial

Ambulatory Pessary Trial as a Preoperative Method for Diagnosing Occult Stress Urinary Incontinence

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02746913
Enrollment
0
Registered
2016-04-21
Start date
2017-11-30
Completion date
2017-12-31
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Incontinence

Keywords

Pelvic, Urodynamic, Vaginal Wall

Brief summary

The purpose of this study is to compare two methods for assessing patients with pelvic organ prolapse for occult stress urinary incontinence. Urodynamic testing is the most widely accepted and well-studied method for diagnosing occult stress urinary incontinence preoperatively, but an ambulatory pessary trial is a less expensive option that is available to a wider group of practitioners and evaluates patient while they are engaged in their daily activities.

Interventions

DEVICEUrodynamics

Urodynamics is performed with the Aquarius XT Laborie system and a fluoroscopic images are obtained with a GE OCE 9800 c-arm fluoroscopy unit. Urodynamic testing will be performed in a seated position with a pessary from the ambulatory pessary trial in place. Post residual void will be measured at the start of the urodynamics.

DEVICEPessary

A pessary is a silicone disc that is used in to support the uterus and vagina of women with vaginal prolapse. During this study, the pessary that will be used is a ring with support. This is a disc shape with a membrane stretched across the center. It is a device used in standard practice and is safe to keep in place for up to 3 months at a time. The subjects will be fit with a pessary asked to wear the pessary for 3 days.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female * Patients planning to undergo pelvic organ prolapse surgery and preoperative urodynamic testing within 6 months of recruitment. * Stage 2 or greater pelvic organ prolapse on pre op POP-Q exam * Negative stress test on clinical exam * Cognitive capacity to complete questionnaires and voiding diary

Exclusion criteria

* Stress incontinence during provocative stress test on pre-operative exam. * Occult stress urinary incontinence demonstrated on pre-operative physical exam * Known ability to retain a pessary for the 3 day trial * \< age 18 * History of bladder augmentation or artificial sphincter * Known neurologic disease effecting bladder (spinal cord injury, Multiple Sclerosis, Parkinson's Disease, etc.) * Non ambulatory patients * Active infections of the vagina or pelvis (Pelvic inflammatory disease, infectious vaginitis, etc.) * Occult stress urinary incontinence demonstrated on pre-operative physical exam * Known ability to retain a pessary for the 3 day trial * \< age 18 * History of bladder augmentation or artificial sphincter * Known neurologic disease effecting bladder (spinal cord injury, Multiple Sclerosis, Parkinson's Disease, etc.) * Non ambulatory patients * Active infr

Design outcomes

Primary

MeasureTime frameDescription
Medical, Epidemiological, and social Aspects of Aging (MESA) questionnaire3 Daysleakage on a voiding diary.
Overactive bladder quality of life (QAB-Q)- short term questionnaire3 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026